Omniscan (Gadodiamide)

Gadodiamide, the active ingredient in Omniscan, is a contrast media presented as a 0.5 ml/0.5 mmol injection for intravenous use. It enhances magnetic resonance imaging (MRI) scans, helping radiologists visualize vascular and tissue structures in patients undergoing diagnostic examinations. GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide.

GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide.

Omniscan is used as an MRI contrast agent to improve visualization of anatomical structures and pathological conditions. - Central nervous system imaging: enhances detection of tumors, demyelinating lesions and vascular malformations. - Cardiovascular imaging: improves delineation of cardiac chambers, great vessels and myocardial perfusion. - Abdominal and pelvic imaging: aids in characterizing liver lesions, renal masses and inflammatory processes.

Adverse reactions to gadodiamide‑based contrast agents vary in frequency and severity.

Common Side Effects: - Nausea: mild, transient discomfort. - Headache: brief, self‑limiting. - Injection site discomfort: mild pain or burning at the infusion site. - Warmth sensation: fleeting feeling of heat during administration.

Serious or Rare Side Effects: - Nephrogenic systemic fibrosis (NSF): fibrotic skin changes in patients with severe renal impairment. - Anaphylactoid reactions: hives, bronchospasm, hypotension. - Severe allergic reactions: angio‑edema, respiratory distress. - Cardiac arrest: extremely rare, may occur with severe anaphylaxis.

When using Omniscan, clinicians should assess patient history and monitor for adverse events. - Renal function assessment: evaluate glomerular filtration rate before administration. - Pregnancy caution: avoid use unless clearly needed, as safety data are limited. - Breastfeeding guidance: consider discontinuation of breastfeeding for a short period after dosing. - Allergic history review: inquire about prior reactions to gadolinium‑based agents. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Omniscan may interact with other substances that affect renal function or provoke hypersensitivity.

Major Interactions (Avoid): - Nephrotoxic drugs: concurrent use with high‑dose aminoglycosides or amphotericin B may increase risk of renal injury.

Moderate Interactions (Monitor Closely): - Diuretics: may alter gadolinium clearance, requiring renal monitoring. - Calcium‑    - Calcium  ---      -   g   g  t  t 

--- ---   ---   ---   ---  ---  ---  --- ---  ---  ---  --- ---  ---  ---  ---  ---  ---  ---  ---  t  ---  g  ---  t  ---  ---  ---  ---  ---  ---  ---  ---  ---

---  ---  --- --- 

---